What is Vertex Pharmaceuticals's exercised (in shares)?

Vertex Pharmaceuticals (VRTX) reported exercised (in shares) of $31.32 in Q4 2025.

What does exercised (in shares) mean?

The total number of shares distributed to satisfy all equity compensation awards.

Exercised (in shares)

Vertex Pharmaceuticals Exercised (in shares) remained flat by 0.0% to $31.32 in Q4 2025 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementIncome Statement

SectionOther

CategoryCapital Allocation

SignalLower is better

VolatilityModerate

First reportedQ1 2025

Last reportedQ4 2025Feb 13, 2026

How to read this metric

Higher numbers indicate greater dilution of existing shareholders through compensation plans.

Detailed definition

The total volume of shares issued or transferred to satisfy obligations under various share-based payment arrangements....

Peer comparison

Standard disclosure in equity and cash flow statements.

Metric ID: other_share_based_compensation_arrangements_by_share_bas_83b57c

Historical Data

1 years

	FY'25
Value	$125.30

Exercised (in shares) at Other Companies

General MotorsGM View metric

MSCIMSCI View metric

Royal Caribbean GroupRCL View metric

Corvex MOVE View metric

Vulcan Materials CompanyVMC View metric

Frequently Asked Questions

What is Vertex Pharmaceuticals's exercised (in shares)?: Vertex Pharmaceuticals (VRTX) reported exercised (in shares) of $31.32 in Q4 2025.
What does exercised (in shares) mean?: The total number of shares distributed to satisfy all equity compensation awards.